$9.84
1.60% yesterday
Nasdaq, Nov 25, 09:17 pm CET
ISIN
US10501L1061
Symbol
BWAY

Brainsway Ltd Sponsored ADR Stock price

$9.74
+0.09 0.93% 1M
+4.34 80.37% 6M
+3.26 50.31% YTD
+3.71 61.53% 1Y
+2.01 26.00% 3Y
+0.34 3.62% 5Y
-1.26 11.45% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.26 2.60%
ISIN
US10501L1061
Symbol
BWAY
Sector

Key metrics

Market capitalization $162.57m
Enterprise Value $114.17m
P/E (TTM) P/E ratio 108.22
EV/FCF (TTM) EV/FCF 19.12
EV/Sales (TTM) EV/Sales 2.96
P/S ratio (TTM) P/S ratio 4.21
P/B ratio (TTM) P/B ratio 3.69
Revenue growth (TTM) Revenue growth 34.19%
Revenue (TTM) Revenue $38.63m
EBIT (operating result TTM) EBIT $1.14m
Free Cash Flow (TTM) Free Cash Flow $5.97m
Cash position $48.40m
EPS (TTM) EPS $0.09
P/E forward negative
P/S forward 4.03
EV/Sales forward 2.83
Short interest 0.33%
Show more

Is Brainsway Ltd Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Brainsway Ltd Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Brainsway Ltd Sponsored ADR forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Brainsway Ltd Sponsored ADR forecast:

Buy
100%

Financial data from Brainsway Ltd Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
39 39
34% 34%
100%
- Direct Costs 9.82 9.82
27% 27%
25%
29 29
37% 37%
75%
- Selling and Administrative Expenses 20 20
10% 10%
51%
- Research and Development Expense 6.58 6.58
11% 11%
17%
2.55 2.55
131% 131%
7%
- Depreciation and Amortization 1.40 1.40
4% 4%
4%
EBIT (Operating Income) EBIT 1.14 1.14
112% 112%
3%
Net Profit 1.50 1.50
118% 118%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Brainsway Ltd Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Brainsway Ltd Sponsored ADR Stock News

Neutral
GlobeNewsWire
6 days ago
BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd.
Neutral
Seeking Alpha
14 days ago
BrainsWay Ltd. (NASDAQ:BWAY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Steven Lichtman - Oppenheimer Jeff Cohen - Ladenburg Thalmann & Company Operator Good day, and welcome to the BrainsWay Third Quarter 2024 Earnings Conference Call.
Neutral
GlobeNewsWire
14 days ago
Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd.
More Brainsway Ltd Sponsored ADR News

Company Profile

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

Head office Israel
CEO Hadar Levy
Employees 106
Founded 2006
Website www.brainsway.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today